Puma Biotechnology (PBYI) EBT (2010 - 2026)
Puma Biotechnology (PBYI) reported EBT of -$3.4 million for Q1 2026, down 204.9% on a YoY basis from $3.3 million in Q1 2025, and down 120.03% quarter-over-quarter from $17.1 million in Q4 2025.
Puma Biotechnology (PBYI) EBT (2010 - 2026) Analysis & Trends
Puma Biotechnology has reported EBT for 17 years, with the latest figure at -$3.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 204.9% year-over-year to -$3.4 million; the trailing twelve-month figure through Mar 2026 stood at $29.1 million (up 269.98% YoY), and the FY2025 full-year result was $35.8 million, changed N/A from the prior year.
- EBT for Q1 2026 stood at -$3.4 million, down from $17.1 million in the prior quarter.
- The five-year high for EBT was $20.6 million in Q3 2024, with the low at -$11.9 million in Q4 2024.
- Historically, EBT has averaged $1.9 million across 5 years, with a median of $1.5 million in 2023.
- Annual changes were most pronounced in 2023 — EBT surged 2150.85% — and 2024, when it slumped 396.83%.
- Puma Biotechnology's EBT stood at -$5.3 million in 2022, then tumbled by 85.81% to -$9.9 million in 2023, then decreased by 20.18% to -$11.9 million in 2024, then jumped by 244.22% to $17.1 million in 2025, then tumbled by 120.03% to -$3.4 million in 2026.
- The last three EBT figures came in at -$3.4 million (Q1 2026), $17.1 million (Q4 2025), and $9.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn | -3.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.43 Mn |
| Dec 31, 2025 | 17.11 Mn |
| Sep 30, 2025 | 9.24 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | -11.86 Mn |
| Sep 30, 2024 | 20.61 Mn |
| Jun 30, 2024 | -4.15 Mn |
| Mar 31, 2024 | -4.60 Mn |
| Dec 31, 2023 | -9.87 Mn |
| Sep 30, 2023 | 6.01 Mn |
| Jun 30, 2023 | 2.31 Mn |
| Mar 31, 2023 | 1.55 Mn |
| Dec 31, 2022 | -5.31 Mn |
| Sep 30, 2022 | -293,000.00 |
| Jun 30, 2022 | 9.43 Mn |
| Mar 31, 2022 | -3.37 Mn |
| Dec 31, 2021 | 4.44 Mn |
| Sep 30, 2021 | -44.64 Mn |
| Jun 30, 2021 | -5.07 Mn |